Caring for the CLL Care Partner - Dr. Chadi Nabhan

(5:14)

Why the ASH Meeting is Important for Patients with CLL

(3:53)

AMPLIFY Trial: Acalabrutinib Plus Venetoclax for CLL

(10:22)

ASH 2024 Comes to You!

(1:30:50)

New Options for Treatment-Resistant CLL - Dr. Meghan Thompson

(5:8)

The Cancer Journey: Diagnosis, Treatment and Prevention - Dr. Chadi Nabhan

(6:8)

Doctor and Cancer Patient Communications - Dr. Chadi Nabhan

(11:59)

Acalabrutinib and Obinutuzumab for Frontline CLL Treatment

(8:31)

Increasing Diversity in CLL Clinical Trials

(6:36)

Progression-Free and Overall Survival Correlation in Relapsed CLL

(6:2)

The Role of Diet in Chronic Lymphocytic Leukemia (CLL) with Dr. Gregory Plotnikoff

(14:34)

Getting the Most from Your CLL Treatment: Managing Side Effects and Knowing When to Stop

(1:30:16)

More Vitamin D in Early CLL Improves Treatment-Free Survival

(19:27)

AMPLIFY Trial: Acalabrutinib Plus Venetoclax for CLL

(10:22)

The Importance of Front-Loading Your Knowledge During the Early Journey of CLL / SLL

(1:27:18)

Time Off Treatment - Chronic Lymphocytic Leukemia (CLL)

(27:31)

ASH 2024 Comes to You!

(1:30:50)

BTK Degrader Offers Promise in Relapsed and Refractory CLL

(10:49)

New Options for Treatment-Resistant CLL - Dr. Meghan Thompson

(5:8)

Beyond Your CLL Diagnosis: Comprehensive Health Management

(1:30:38)

BTKi Resistance Mutations in Chronic Lymphocytic Leukemia (CLL)

(30:28)

Just Diagnosed: What Do I Need to Know?

(58:33)

Common Infections with CLL: Prevention and Treatment

(1:31:50)

CLL Society Facebook Live \

(59:53)

CLL Society Facebook Live \

(59:15)

Test Before Treat - Nathan's Story

(2:41)

Vitamin D Associated with Longer Treatment-Free Survival in Early CLL

(16:30)

Treatment Options for CLL after Bruton’s Tyrosine Kinase Inhibitor and Venetoclax (BCL2i) - ASH 2021

(12:40)